Journal of Clinical Investigation · 2017 · 79 citations · 67 references
Life SciencesImmunologyMicrobiologyImmunizationVaccine ImmunologyVaccinologyAntigen DesignCell-surface GlycansConjugate VaccinesVaccine Antigen DesignVaccine PlatformsVirus-like Particle VaccinesAntibodiesAntibody Glycan RecognitionBacterial PolysaccharidesCd4 Positive T CellsGlycan-based ConjugationGlycoconjugate Vaccine DesignPneumococcal Conjugate VaccinesPolysaccharide Vaccines
Vaccines targeting glycan structures at the surface of pathogenic microbes must overcome the inherent T cell-independent nature of immune responses against glycans. Carbohydrate conjugate vaccines achieve this by coupling bacterial polysaccharides to a carrier protein that recruits heterologous CD4 T cells to help B cell maturation. Yet they most often produce low- to medium-affinity immune responses of limited duration in immunologically fit individuals and disappointing results in the elderly and immunocompromised patients. Here, we hypothesized that these limitations result from suboptimal T cell help. To produce the next generation of more efficacious conjugate vaccines, we have explored a synthetic design aimed at focusing both B cell and T cell recognition to a single short glycan displayed at the surface of a virus-like particle. We tested and established the proof of concept of this approach for 2 serotypes of Streptococcus pneumoniae. In both cases, these vaccines elicited serotype-specific, protective, and long-lasting IgG antibodies of nanomolar affinity against the target glycans in mice. We further identified a requirement for CD4 T cells in the anti-glycan antibody response. Our findings establish the design principles for improved glycan conjugate vaccines. We surmise that the same approach can be used for any microbial glycan of interest.
67
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Masahiro Yamamoto, Shintaro Sato, Hiroaki Hemmi et al. · Science · 2003 · 3.2K citations
Solvent-Accessible Surfaces of Proteins and Nucleic Acids
Michael L. Connolly · Science · 1983 · 2.7K citations
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Osamu Adachi, Taro Kawai, Kiyoshi Takeda et al. · Immunity · 1998 · 2K citations · Full text